MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Compound heterozygous mutation of the Beta galactosidase 1 gene presenting with familial dystonia and spondylo-epiphyseal dysplasia

A. Elavarasi, A. Anand, A. Garg, K. Garg, M. Singh, M. Tripathi, D. Vibha, R. Singh (New Delhi, India)

Meeting: 2022 International Congress

Abstract Number: 545

Keywords: Basal ganglia, Brain iron accumulation, Dystonia: Clinical features

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To describe a family with dystonia and spondylo-epiphyseal dysplasia

Background: Childhood onset Generalized dystonia is usually associated with genetic causes.

Method: We present a family in which 3 siblings were affected with generalized dystonia.

Results: Case description
Along with dystonia, the children had a short stature, coarse facial features and also had hypotonia with hyperreflexia. Our index patient had a height of 150 cm and an arm span of 174 cm.
Imaging revealed iron deposition in the basal ganglia, with a linear T2/FLAIR hyperintensity in the globus pallidus, suggesting a NBIA spectrum disorder.
Whole exome sequencing revealed a compound heterozygous mutation in the GLB1 gene. His urinary tandem mass spectrometry was consistent with Mucopolysaccharidosis Type IV.

Conclusion: Discussion
GM1 gangliosidosis and Mucopolysaccharidosis Type IV are two different phenotypic presentations of beta-galactosidase 1 deficiency, a lysosomal hydrolase, due to autosomal recessive mutations in the GLB1 gene.
The defective storage of keratan sulfate presents with a mucopolysaccharidosis IV phenotype (Morquio B disease) while GM1 gangliosidosis presents with neurovisceral manifestations if there is defective hydrolysis of gangliosides, lactosylceramide, asialofetuin, oligosaccharides carrying terminal β-linked galactose and keratan sulfate. Morquio Type B disease is associated with spondyloepiphyseal dysplasia of the spine and long bones. While the GM1 gangliosidosis presents with dystonia, ataxia, cognitive impairment and may be associated with visceromegaly.
Conclusion
This is the first reported case in literature with both skeletal and neurologic manifestations. It is also worth noting that the patient also had imaging consistent with NBIA spectrum disorder, however none of the mutations associated with NBIA were found on whole exome sequencing.

Figure 1

To cite this abstract in AMA style:

A. Elavarasi, A. Anand, A. Garg, K. Garg, M. Singh, M. Tripathi, D. Vibha, R. Singh. Compound heterozygous mutation of the Beta galactosidase 1 gene presenting with familial dystonia and spondylo-epiphyseal dysplasia [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/compound-heterozygous-mutation-of-the-beta-galactosidase-1-gene-presenting-with-familial-dystonia-and-spondylo-epiphyseal-dysplasia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/compound-heterozygous-mutation-of-the-beta-galactosidase-1-gene-presenting-with-familial-dystonia-and-spondylo-epiphyseal-dysplasia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley